Ketamine clinics are booming across the US. According to psychedelic fund PsyMed, there were around 20 ketamine clinics in 2019. By the end of last year, there were reportedly over 600 independent ketamine clinics, as well as chains like Mindbloom, Field Trip and Delic with multiple clinics and home delivery services. Since the pandemic began, ketamine start-ups have reported rapid growth: in 2022, Field Trip reported 200% yearly growth, Mindbloom reported 420% employee growth, and Delic says its net assets grew 500% in a year. Profits from ketamine grew from $8.3 million in 2017 to $185 million in 2022… […]

Ketamine companies are riding the wave of psychedelic hype. There’s so much excitement about psilocybin therapy, but it’s been slow to get FDA approval. Meanwhile, people are desperate for relief from mental and physical health problems, and investors are impatient for returns. Ketamine already has FDA approval as an anaesthetic. Any US medical provider can apparently offer it off-label for whatever condition they want, from depression and anxiety to OCD and eating disorders, to alcoholism, drug addiction, schizophrenia, bipolar disorder, self-esteem issues, self-actualization…you name it!

https://ecstaticintegration.substack.com/p/ketamine-the-psychedelic-renaissance